Abstract:Epidermal growth factor (EGF) signaling and Hedgehog (HH) signaling are both involved in prostate cancer (PCa) progression, yet the mechanisms through which these two pathways are synergistically linked require elucidation. In the present study, we aimed to ascertain how EGF and the HH signaling transcription factor GLI-1 are linked in prostate cancer invasiveness. ARCaP human prostate cancer cells, which included ARCaP(E) and ARCaP(M) cells, were used as a model in the present study. The expression of EGF receptor (EGFR) and the HH signaling transcriptional factor GLI-1 were detected in ARCaP(E) cells by immunofluorescence, and the ARCaP(E) cells were treated with human recombinant EGF protein (hrEGF) for 4 consecutive days in vitro. Transwell invasion assays were performed in the ARCaP(E) cells following treatment with DMSO (vehicle control), hrEGF, GATN61 (GLI-1-specific inhibitor), hrEGF plus GANT61 and in the ARCaP(M) cells. The expression of phosphorylated extracellular signal regulated kinase (p-ERK), total ERK and GLI-1 was detected by western blotting in ARCaP(E) cells at different time-points following treatment with hrEGF. The expression of EGFR and GLI-1 was detected in ARCaP(E) cells, which exhibited a cobblestone-like morphology, while after treatment with hrEGF, the cell morphology was altered to a spindle-shaped mesenchymal cell morphology. Transwell invasion assays demonstrated that hrEGF dramatically enhanced the invasive capability of the ARCaP(E) cells (P<0.05). Additionally, western blot assay demonstrated that the expression levels of p-ERK and GLI-1 in ARCaP(E) cells increased in a time-dependent manner after treatment with hrEGF (P<0.05); however, the expression levels of total ERK in the cells remained relatively unchanged. It also demonstrated that the GLI-1 inhibitor GANT61 could reverse the enhanced invasive effect induced by EGF in ARCaP(E) cells (P<0.05). Our preliminary in vitro study showed that EGF signaling may increase the invasive capability of ARCaP(E) human prostate cancer cells via upregulation of p-ERK and the HH signaling transcriptional factor GLI-1. Additionally, this enhanced cell invasive effect was reversed by a GLI-1-specific inhibitor in vitro. Consequently, it indicates that both EGF and HH signaling are synergistically involved in the progression of human prostate cancer ARCaP cells, and GLI-1 may be one of the important effectors, which is activated by EGF downstream signaling, to promote the invasiveness of ARCaP(E) prostate cancer cells.

Phospholipase-C gamma-1 (PLCγ-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells

Oncogenic Role of Phospholipase C‐γ1 in Progression of Hepatocellular Carcinoma

Phospholipase D as a key modulator of cancer progression

Role of GLI-1 in Epidermal Growth Factor-Induced Invasiveness of ARCaP(E) Prostate Cancer Cells

Phospholipase D (PLD) drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model

Placenta Growth Factor, PLGF, Influences the Motility of Lung Cancer Cells, the Role of Rho Associated Kinase, Rock1

Expression of Phospholipase C Isozymes in Human Breast Cancer and Their Clinical Significance

Hepatocyte Growth Factor Up-Regulates the Expression of the Bone Morphogenetic Protein (BMP) Receptors, BMPR-IB and BMPR-II, in Human Prostate Cancer Cells.

Phospholipase Cε Regulates Prostate Cancer Lipid Metabolism and Proliferation by Targeting AMP-Activated Protein Kinase (AMPK)/Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Signaling Pathway

PLCγ1–PKCγ Signaling‐Mediated Hsp90α Plasma Membrane Translocation Facilitates Tumor Metastasis

Correlation of calcium-independent phosphatidylcholine-specific phospholipase C with γ-GT in hepatoma cells

Characterization of Phosphoglycerate Kinase-1 Expression of Stromal Cells Derived from Tumor Microenvironment in Prostate Cancer Progression

PLGF Regulates Crosstalk Between Non-Small Cell Lung Cancer Cells and Tumor-Associated Macrophages in Cancer Vascularization and Growth

[GLI-1 is Involved in EGF-regulated Enhancement of the Invasiveness of Prostate Cancer ARCaP(E) Cells in Vitro].

PDGF Receptor-Α Promotes TGF-β Signaling in Hepatic Stellate Cells Via Transcriptional and Posttranscriptional Regulation of TGF-β Receptors.

Knockdown of WAVE3 Impairs HGF Induced Migration and Invasion of Prostate Cancer Cells

Endogenous Bone Morphogenetic Protein-7 Controls the Motility of Prostate Cancer Cells Through Regulation of Bone Morphogenetic Protein Antagonists

[Influence of Phosphoglycerate Kinase 1 on Metastasis and Invasion of Hepatoma Cells and Prognosis of Liver Cancer].

cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells.

[Influence of Phosphoprotein Associated with Glycosphingolipid Microdomains 1 on Biologic Behavior of Human Prostatic Cancer Cell Line In-Vitro].

Phosphoprotein associated with glycosphingolipid microdomains 1 inhibits the proliferation and invasion of human prostate cancer cells in vitro through suppression of Ras activation.